SCHEMBL7631719

SCHEMBL7631719

COc1ccc(C(=O)Nc2ccc(Cl)cc2)c(NS(=O)(=O)c2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC20A2 Q08357 1/20 0.86
SLC20A1 Q8WUM9 1/20 0.86
USP2 O75604 1/20 0.64
USP8 P40818 1/20 0.64
AVPR2 P30518 4/20 0.52
GPR27 Q9NS67 4/20 0.52
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RXFP1 Q9HBX9 2/20 0.49
GAA P10253 2/20 0.49
PLAU P00749 1/20 0.49
PLAT P00750 1/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ACLY P53396 1/20 0.49
AKR1C3 P42330 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128814 0.93 SLC20A2 (1.00) SLC20A2SLC20A1USP2USP8AVPR2
SCHEMBL7208743 0.89 SLC20A2 (0.70) SLC20A2SLC20A1USP2USP8AVPR2
SCHEMBL7120286 0.85 SLC20A2 (0.74) SLC20A2SLC20A1AVPR2GPR27MEN1
SCHEMBL7126685 0.83 SLC20A2 (0.83) SLC20A2SLC20A1USP2USP8AVPR2
SCHEMBL27575234 0.81 SLC20A2 (0.57) SLC20A2SLC20A1USP8AVPR2GPR27
SCHEMBL7530790 0.79 SLC20A2 (0.65) SLC20A2SLC20A1AVPR2GPR27MEN1
SCHEMBL7144951 0.79 GPR27 (0.70) SLC20A2SLC20A1USP2USP8AVPR2
SCHEMBL7572438 0.78 SLC20A2 (0.63) SLC20A2SLC20A1USP2USP8MEN1
SCHEMBL12201483 0.78 SLC20A2 (0.72) SLC20A2SLC20A1USP2USP8MEN1
SCHEMBL23200355 0.77 MEN1 (0.67) SLC20A2SLC20A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed